Drug
Abp 501
Abp 501: highest development phase Phase 3, developed by Amgen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Amgen
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABP 501 NCT02114931 | Phase 3 | Arthritis, Rheumatoid |
Latest
No recent events.
Follow Abp 501 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.